The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent insulin secretion, suppressed glucagon secretion, and reduced appetite
Ted Hackstadt, NIH/NIAID Rocky Mountain Laboratories), or antibody specific for Rickettsia japonica OMP (Invitrogen, PA5-117668)
Beyond direct pancreatic effects, GLP-1 therapy is associated with improved insulin sensitivity in peripheral tissues, particularly skeletal muscle and adipose tissue
Frequently Asked Questions How large is the demand for GLP-1 receptor agonists in the global market in 2026
Individual outcomes can differ, and based on their unique situations, some individuals may lose more or less weight
,